Connection

Chenjian Gu to Antibodies, Neutralizing

Back to Details
This is a "connection" page, showing publications Chenjian Gu has written about Antibodies, Neutralizing.
Chenjian Gu
Connection Strength
0.211
Antibodies, Neutralizing
  1. A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge. Emerg Microbes Infect. 2021 Dec; 10(1):1555-1573.
    View in: PubMed
    Score: 0.035
  2. A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2. Front Immunol. 2021; 12:653189.
    View in: PubMed
    Score: 0.033
  3. Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV. MAbs. 2021 Jan-Dec; 13(1):1953683.
    View in: PubMed
    Score: 0.032
  4. RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response. Signal Transduct Target Ther. 2020 11 27; 5(1):282.
    View in: PubMed
    Score: 0.032
  5. Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China. JAMA Intern Med. 2020 10 01; 180(10):1356-1362.
    View in: PubMed
    Score: 0.032
  6. Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection. Cell Rep. 2020 07 21; 32(3):107918.
    View in: PubMed
    Score: 0.031
  7. Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections. Nat Commun. 2021 01 11; 12(1):264.
    View in: PubMed
    Score: 0.008
  8. Identification of Human Single-Domain Antibodies against SARS-CoV-2. Cell Host Microbe. 2020 06 10; 27(6):891-898.e5.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.